Group Column - Director, Ngm Biopharmaceuticals Inc

As of September 3, 2020


Group Column Net Worth

  • Net worth is estimated to be at least $85.96M
  • Owns at least 2,017,025 units of Ngm Biopharmaceuticals Inc stock

Group Column Trading

  • Largest purchase of shares was 14,983,134 units , worth over $30.24M on April 10, 2019
  • In total has made about 63 transactions over a year
  • Usually trades in August and July, with the busiest year in 2020

GROUP COLUMN, COLUMN GROUP III LP, COLUMN GROUP IIIA LP, COLUMN GROUP III GP LP, Peter Svennilson, DAVID GOEDDEL V

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Group Column Mailing Address

  • Mailing address is 1700 Owens Street Suite 500 San Francisco CA 94158 CA

Ngm Biopharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
David J. Woodhouse, Ph.D. 2020 $525,000 $200,000 $3,833,880 $750 $4,559,630
David J. Woodhouse, Ph.D. 2019 $490,000 $125,000 $1,476,400 $750 $2,092,150
Siobhan Nolan Mangini 2020 $199,695 $155,000 $3,458,520 $750 $3,813,965
Jin-Long Chen, Ph.D. 2020 $515,000 $175,000 $1,677,323 $750 $2,368,073
Jin-Long Chen, Ph.D. 2019 $500,000 $125,000 $1,291,850 $750 $1,917,600
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1426332/000162828021007942/ngmbiopharmaceuticalsinc-d.htm

Ngm Biopharmaceuticals Inc Insider Trading

  • The most recent transaction was 30,000 units sold on October 13, 2021 by Jin-Long Chen worth over $608.25K
  • In the last 2 years, insiders at Ngm Biopharmaceuticals Inc sold an estimated value of $10.91M and bought an estimated value of $277.28M
  • The most active traders are Group Column, Director,  David Goeddel V, Director,  and Peter Svennilson
  • Insider trading is most common in June, with the busiest year in 2019

NGM BIOPHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1